
PLXP
Healthcare · Pharmaceuticals · $2.5M market cap
Latest report
Time not confirmed
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2022
EPS trend, 90 days to now · 0.0% over 90 days · 30-day revisions 0 up, 0 down
Beat estimates in 4 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| May 12, 2023 | Time not confirmed | -0.35 | 0.00 | +100.0% |
| Mar 10, 2023 | Time not confirmed | -0.28 | 0.00 | +100.0% |
| Nov 10, 2022 | After the close | -0.44 | -0.30 | +31.8% |
| Aug 12, 2022 | Before the open | -0.56 | -0.43 | +23.2% |
| May 13, 2022 | Before the open | -0.72 | -0.39 | +45.8% |
| Mar 11, 2022 | Before the open | -0.71 | 0.10 | +114.1% |
| Nov 12, 2021 | Before the open | -0.46 | -0.80 | -73.9% |
| Aug 6, 2021 | Before the open | -0.22 | -0.79 | -259.1% |
| May 14, 2021 | Before the open | -0.21 | -0.73 | -247.6% |
| Mar 12, 2021 | Before the open | -0.29 | -0.87 | -200.0% |
| Nov 13, 2020 | After the close | -0.42 | -0.40 | +4.8% |
| Aug 14, 2020 | Before the open | -0.41 | -0.66 | -61.0% |
| May 15, 2020 | Before the open | -0.39 |
PLx Pharma Inc. operates as a commercial-stage drug delivery platform technology company in the United States. The company's lead product candidates are Vazalore 325 mg for the patients with vascular events, such as heart attacks and clot-related strokes, as well as for use in conditions associated with pain and inflammation, including other aspirin and non-steroidal anti-inflammatory drug products; and Vazalore 81…
| 0.08 |
| +120.5% |
| Mar 13, 2020 | Before the open | -0.48 | -0.25 | +47.9% |
| Nov 8, 2019 | Before the open | -0.49 | 0.09 | +118.4% |
| Aug 9, 2019 | Before the open | -0.43 | -1.10 | -155.8% |
| May 10, 2019 | Before the open | -0.33 | -1.24 | -275.8% |
| Mar 8, 2019 | Before the open | -0.37 | 0.34 | +191.9% |
| Nov 9, 2018 | Before the open | -0.39 | -0.39 | 0.0% |
| Aug 10, 2018 | Before the open | -0.40 | -0.41 | -2.5% |
| May 11, 2018 | Before the open | -0.44 | 0.57 | +229.5% |
| Mar 23, 2018 | Before the open | -0.53 | -0.64 | -20.8% |